EDITORIAL SECTION

  • STRATEGY

    Smarter Pharma

    Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products

  • EXPERT Talk

    Compliance to Competitive Advantage in Pharma Supply

    Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser

KNOWLEDGE BANK

  • Articles

    How to Optimize Batch Production in European Pharmaceutical Manufacturing?

    Efficient and highquality batch production is crucial for success in the European pharmaceutical industry This short introduction explores key strategies for optimizing manufacturing processes

    COVID-19 Vaccines & SARS-CoV-2 Variants: Who is winning the Race?

    It was not uncommon to name the year as annus horribilis as the SARSCoV quickly spread all over the globe causing the first pandemic in years leading to devastating consequences on health economy and the society in general Neither drugs nor vaccines were available for more or less the whole first year of the pandemic causing devastation helplessness and uncertainty Since the beginning of the COV...

    Why Leading Pharma Professionals Rely on the Pharma Focus Europe E-Newsletter

    The network of the pharmaceutical and life sciences in Europe is undergoing a radical transformation There are changes in the regulatory environments a rise in the pace of innovation a shift in leadership and a change in the distribution production and development of therapies by the use of digital technologies In this environment no longer will access to timely credible and context rich informati...

    The Rise of Bioprinting: Opportunities and Challenges for Personalized Sterile Dosage Forms

    Personalized medicine also known as precision medicine has gained significant traction in recent years transforming the healthcare landscape By considering an individuals unique genetic molecular and environmental factors personalized medicine aims to provide targeted therapies that maximize treatment effectiveness while minimizing adverse effects This approach

    Trapicolast Emerges as a First-In-Class Response to Drug Resistance: The Weakest

    Malaria remains one of the worlds most persistent infectious diseases Each year it infects hundreds of millions and causes more than half a million deaths with subSaharan Africa bearing the overwhelming burden Children under five account for most fatalities highlighting malarias deep inequity

    Data Security Challenges in Pharma IT: Safeguarding Sensitive Information

    The pharmaceutical industry faces several data security challenges in its IT infrastructure primarily related to safeguarding sensitive information The nature of the data regulatory requirements and the increasing sophistication of cyber threats

TOP ARTICLES

press releases Read more...

BioLife receives US patent for novel effervescent tablet technology for oral peptide delivery

BioLife announced today that the US Patent and Trademark Office has granted US Patent B for its novel oral peptide delivery technology via effervescent tablets It was developed for current and future peptide therapies for obesity diabetes and metabolic disorders

Prelude Therapeutics Receives FDA Clearance of Investigational New Drug (IND) Application for PRT13722, Its First-in-Class Oral KAT6A Selective Degrader

Prelude Therapeutics Incorporated Nasdaq PRLD a precision oncology company today announced that the US Food and Drug Administration FDA cleared the Company to proceed with a Phase study under

Electra Therapeutics Announces Initiation of a Phase 1 Trial of ELA822, a Novel SIRPγ-Specific Antibody Designed to Treat T Cell-Mediated Immune and Inflammatory Diseases

Electra Therapeutics a clinicalstage biopharmaceutical company focused on pioneering a new class of precision medicines for the treatment of immunemediated diseases and cancer today announced

Insilico Medicine Doses First Patient in GENESIS-IPF-3, the World's First Phase III Trial of a Generative AI-Driven Innovative Drug

Insilico Medicine Insilico HKEX a clinicalstage biotechnology company powered by generative AI today announced that it has dosed the first patient with Rentosertib known as ISM INS

14 - 15

Sep 2026

16th American DDF Summit

Omni Boston Hotel at the Seapo...

15 - 17

Sep 2026

COPD Drug Development Summit 2026

Street, Boston, MA 02210, USA

21 - 23

Sep 2026

21 - 23

Sep 2026

Cancer R&D World Conference

Hilton Garden Inn Miami Dolphi...

22 - 23

Sep 2026

22 - 24

Sep 2026

28 - 01

Sep 2026

LATEST NEWS Read more...

Renova Pharmaceuticals Launches First Three US Generic Products

Renova Pharmaceuticals has launched its first three generic products in the US marking a major milestone as the company moves from developing its product and regulatory pipeline to establishing a commercial presence in the US generics market

Community Clinical Research Joins PhaseWell Research to Expand CNS Clinical Trial Access in Te

PhaseWell Research has partnered with Community Clinical Research CCR in Austin Texas to strengthen its inpatient central nervous system CNS research capabilities and expand access to clinical trials across Texas

Sysmex Europe and Cytek Biosciences collaborate to expand access to advanced clinical flow cytometry

Sysmex Europe SE and Cytek Biosciences Inc have announced a strategic collaboration across more than a dozen European countries to improve clinical flow cytometry workflows and expand access to advanced diagnostic solutions

Ratio Therapeutics and RayzeBio enter collaboration to advance novel radiopharmaceutical programme

Ratio Therapeutics Inc has entered into a research collaboration and licence agreement with RayzeBio Inc to advance a new radiopharmaceutical programme focused on two undisclosed targets

HCW Biologics Signs Exclusive Distribution Agreement with Akron Biotech for HCW11-006

HCW Biologics Inc a USbased clinicalstage biopharmaceutical company has entered into an exclusive distribution agreement with Akron Biotech to commercialise HCW as a reagent for producing highly functional human CART cells

Sernova and Seraxis to Merge and Form BetaNova Biotherapeutics for Type 1 Diabetes Cell Replacement

Sernova Biotherapeutics Inc and Seraxis Holdings Inc have entered into a definitive merger agreement to combine their technologies and create BetaNova Biotherapeutics a clinicalstage biotechnology